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1. Introduction 
The major hormone secreted by the human placen- 
ta in early pregnancy is human chorionic gonado- 
tropin (hCG). This polypeptide hormone is composed 
of two non-identic~ subunits, a! and fi. In placenta 
the a subunit is the predominant subunit synthesized 
and far exceeds the production of /? subunit [l-2]. 
Recent studies using cell-free translation of mRNA 
isolated from first trimester placentae have shown 
that the cy subunit is synthesized as a pre-protein like 
many other secretory proteins [3--S]. The (Y subunit 
of hCG is a glycoprotein containing two identical 
oligosaccharide chains which represent 30% of its 
molecular weight [ 61. The carbohydrate chains are 
linked through an Nglycosidic bond to asparagine 
residues located at positions 52 and 78 in the poly- 
peptide chain. The basic structure of these N-glyco- 
sidic carbohydrate units, determined in [7], is: 
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The Xen~~~s oocyte translation system is fre- 
quently used for its capacity to modify many of the 
newly synthesized poIypeptides after translation just 
as the cell from which the mRNA originated [S]. In 
this respect the oocytes are known to glycosylate 
newly synthesized heterologous proteins [9,10] but 
to what extent this process reflects the in vivo situa- 
tion remains to be elucidated. Here, we present evi- 
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dence that microinject~on of mid-term placental RNA 
directs the synthesis of a glycosylated form of hCG-o, 
which has a different carbohydrate composition as 
compared with the authentic hormone. No mature 
a! subunit could be detected in the oocytes. 
2. Materials and methods 
The preparation of total RNA from human term 
and mid-term placentae and the subsequent separa- 
tion of mRNA from ribosomal RNA by affinity 
chromatography on oligo(dT)-cellulose was done 
essentially as in [ 111. The poly(A)-containing RNA 
obtained was dissolved in sterile water and stored at 
-80°C. Batches of 1 S-20 oocytes of Xenopus laevis 
were microinjected with 50 nl poly(A)-containing 
RNA (0.3 mglml). Each set of oocytes was then 
incubated in the presence of 200 PCi [3H]proline 
(117 Ci/mmol, Radiochemical Centre, Amersham) or 
[3H]mannose (22 Ci/mmol, New England Nuclear) 
[ 11). After incubation, the oocytes were homogenized 
in 500 t.ll phosphate-buffered saline. Debris were 
removed by centrifugation (60 min at 105 000 X g) 
prior to analysis of the peptides synthesized. Transla- 
tion of the different RNA preparations was also 
assayed in the wheat germ cell-free system as outlined 
in 1121. 
The synthesized proteins were analyzed by immu- 
noprecipitation with a specific antiserum generated 
against the purified reduced and carboxymethylated 
(Y subunit of hCG. Aliquots (25 ~1) of the cell-free 
translation mixture or the oocyte supernatant were 
incubated for 1 h at 37’C in a total volume of 200 ~1 
phosphate-buffered saline containing 1% Triton 
X-100, 1% sodium deoxycholate and 1 ~1 hCG-o 
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antiserum. Then 10 ~1 goat anti-rabbit antiserum in sodium citrate (pH 5 5); then 0.01 unit endoglyco- 
(Calbiochem AG, Buchs) were added and the incuba- sidase H (Miles) was added and the mixture was incu- 
tion was continued for an additional 1 h at 37°C and bated for 6 h at 37°C. After incubation, the mixture 
16 h at 4°C. The washed immunoprecipitates were was adjusted to pH 7 and immunoprecipitated as 
dissolved either in 1 ml Lumasolve for counting or above. Treatment of the oocyte products with 
in gel sample buffer for analysis by SDS-polyacryl- ol-mannosidase (EC 3.2.1.24; Boehringer, Mannheim) 
amide gel electrophoresis on 15% slab gels [ 121. was as in [lo]. 
To study the effect of glycosidase treatment on 
the oocyte products, 50 ~1 aliquots of the super- 
natant of mRNA-injected oocytes were made 50 mM 3. Results 
Fig.1. Sodium dodecylsulfate polyacrylamide gel electro- 
phoresis of proteins synthesized in a wheat germ system pro- 
grammed with placental mRNA. Poly(A)-containing RNA 
isolated from term or mid-term placenta was translated in the 
cell-free system in the presence of [3H]leucine or [3H]- 
proline. Synthesized peptides were either precipitated with 
trichloroacetic acid (2-4) or immunoprecipitated with 
hCG* antiserum (5). The resulting precipitates were dis- 
solved in SDS buffer and examined on 15% SDS-polyacryl- 
amide slab gels. (1) 14C-Labeled Mr markers: bovine serum 
albumin (68 000); chymotrypsinogen A (25 700); hPL 
(22 000); cytochrome c (12 400); (2) + term placenta 
mRNAin the presence of [‘Hlleucine; (3) + mid-term placenta 
mRNA in the presence of [ “Hlleucine; (4) + mid-term pla- 
centa mRNA in the presence of [‘Hlproline; (5) products of 
(4) immunoprecipitated with hCG-o antiserum. The gel was 
exposed to fluorography. The arrows indicate the positions 
of pre-hPL and prehCG+ The same amount of radioactivity 
was applied into (3,4); the pre-hCG* band in (3) is weak 
because this protein contains 4-times less leucine than pre- 
hPL [5,13,14]. 
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Poly(A)containing RNA was prepared from nor- 
mal term placenta and from mid-term placenta 
(20 weeks) made available to us after a therapeutic 
abortion. As a routine the different RNA prepara- 
tions were tested in the wheat germ cell-free protein 
synthesizing system and the translation products were 
analyzed on SDS-polyacrylamide gels (fig.1). Term 
placental mRNA directed the synthesis of a major 
product with app. Mr 25 000 (fig.1 (2)) which was 
identified as the precursor of human placental lac- 
togen (pre-hPL; [ 121). Analysis of the products 
synthesized in response to mRNA from a mid-term 
placenta revealed the presence of an additional dis- 
tinct radioactive polypeptide with app. IV, 14 000 
(fig.1 (394)). 
Immunoprecipitation was utilized to identify this 
polypeptide. As seen in fig.1 (5) a specific antiserum 
generated against the reduced carboxymethylated 
CY subunit of human chorionic gonadotropin (hCG) 
successfully precipitated the 14 000 Mr product. This 
result gives presumptive evidence that the labeled 
14 000 &I, product contains hCG* sequences and 
represents the precursor of the hCG-o apoprotein in 
‘[3-51. Quantitation of the labeled cr protein by 
immunoprecipitation revealed that it contained 2-3% 
of the total radioactivity incorporated as [ 3H] proline 
into protein by the wheat germ system programmed 
with mRNA from a mid-term placenta, and 0.5% 
when the system was programmed with term placen- 
tal mRNA. 
Consequently, to study the synthesis of hCG-o in a 
whole cell system, the Xenopus oocyte, the poly(A)- 
containing RNA from mid-term placenta was utilized. 
Full-grown oocytes were microinjected with either 
placental mRNA or with injection buffer alone and 
incubated in the presence of [3H]proline. Since mul- 
tiple labeled acid-precipitable proteins were synthe- 
sized both in the absence or in the presence of added 
mRNA, immunoprecipitation was essential to dif- 
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ferentiate synthesized placental peptides from endog- 
enous oocyte peptides. Accordingly, aliquots of the 
oocyte supernatant were immunoprecipitated with 
the specific hCG_tr antiserum. Analysis by SDS- 
polyacrylamide gel electrophoresis of the immuno- 
precipitated proteins demonstrated a prominent 
[3H]proline-containing polypeptide with app. 
&fr 20 000 (fig.2, (3)). No radiolabeled peptides were 
precipitable from the extracts of the oocytes injected 
with buffer (fig.2 (6)). Because Xenopus oocytes are 
able to perform several post-translational modifica- 
tions on newly synthesized heterologous proteins 
[S,l 11, we anticipated that the 20 OOOMr polypep- 
tide represented a processed and glycosylated form 
of hCG-a. However, the migration of the immuno- 
reactive oocyte product was obviously not identical 
to that of native hCG4, since the mature glycosylated 
(II subunit has app. Mr 22 500 on SDS gels (fig.2). 
Batches of oocytes micro~jected with placental 
mRNA were also incubated in the presence of [“HI- 
Fig.2. Fluorograph on the hCG-o related polypeptide syn- 
thesized in Xenopus oocytes. The oocytes were microinjected 
with mRNA isolated from a mid-term placenta and incubated 
in the presence of [3H]proline or [3H]mannose. Following 
incubation the synthesized proteins were immunoprecipi- 
tated with hCG_o antiserum and analyzed on SDS-polyacryl- 
amide slab gels. Digestion of the immunoreactive oocyte 
products with the glycosidases was as in section 2. (1) r4C- 
LabeledMr markers: chymotrypsinogen A (25 700); hPL 
(22 ZOO); cytochrome c (12 400); (2) [3H]manno~~beied 
hCGiv synthesized in oocytes; (3) [‘H]proline~abeled hCGa 
synthesized in oocytes; (4) as in lane 3 but after treatment 
with ~-m~osidase; (5) after treatment with endoglyco- 
sidase H; (6) immunoprecipitate obtained from buffer- 
injected oocytes. The arrow indicates the position of authen- 
tic hCG_cu. 
mannose. As can be seen in fig.2 (2) [3H]mannose 
was incorporated into one poIy~ptide immunopre- 
cipitable with the hCG4 antiserum and comigrating 
with the [311]proline-labeled immunoreactive prod- 
uct. These data suggest hat the 20 000 1wr poly- 
peptide synthesized in oocytes in response to micro- 
injected placental mRNA is glycosylated and contains 
mannose residues. 
To investigate the sugar composition of the hCGiv 
related polypeptide, we treated it with different gly- 
cosidases. ct-Mannosidase apparently removed a con- 
siderable amount of sugar from the glycosylated 
product as shown by its shift in migration (fig.2 (4)). 
The product of this exoglycosidase treatment appeared 
to have app. Mr 15 000 on SDS gels. This finding sug- 
gests the presence of mannose residues at the non- 
reducing ends of the attached glycocores. Further- 
more, the marked increase in mobility of the oocyte 
product after ff-mannosidase treatment indicates that 
it contains several mannose residues linked together 
in a-anomeric configuration. Native hCG-o, of which 
the carbohydrate chains end with sialic acid [7], was 
insensitive to the action of o-mannosidase (not shown). 
Further evidence that the 20 000 M, polypeptide 
contains high-mannose core carbohydrate units was 
obtained by digestion of aliquots of oocyte super- 
natant with endoglycosidase H. This enzyme splits 
the asparagine-bound i-l\i-acetyl-chitobiose when 
linked to a high-mannose type glycocore [ 151. 
Immunoprecipitation of the digested oocyte extracts 
with hCGir antiserum resulted in the appearance of 
a band with app.Mr 14 800 (fig.2 (5)). Treatment of 
authentic hCG_cu with endo~ycosidase H had no 
effect, because the native a! subunit has two complex 
type carbohydrate chains attached to asparagine resi- 
dues [7]. These data are consistent with the idea that 
the hCGa related oocyte product (20 000 Mr) con- 
tains immature high-mannose core oligosaccharide 
units which are not processed up to the carbohydrate 
composition found in native hCG*. 
4. Discussion 
Microinjection of the mRNA isolated from a mid- 
term placenta into Xenopus oocytes results in the 
formation of a glycosylated polypeptide immuno- 
precipitable with hCG-o antiserum and having app. 
M, 20 000. Evidence for glycosylation was: (i) [3H]- 
mannose was specifically incorporated into this 
107 
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oocyte product; and (ii) the migration of this protein highly specific hCGir antiserum. This study was sup- 
on SDS gels was sensitive to the action of different ported by grants from the Belgian Fonds voor Genees- 
glycosidases. kundig Wetenschappelijk Onderzoek. 
Part of the popularity of the Xenopus oocyte SYS- 
tern for the translation of heterologous mRNAs is 
related to its capacity to modify many of the newly 
synthesized polypeptide chains just as the cell from 
which the mRNA originated [8]. One of the post- 
synthetic modifications that is known to occur in the 
oocytes is glycosylation [9,10], but it was not yet 
examined whether this process parallels the in vivo 
events. These results indicate that the glycosylated 
hCGiv related polypeptide synthesized in the oocytes 
is not identical to the mature (Y subunit. The mobility 
of the immunoreactive oocyte product on SDS gels 
is somewhat greater than that of the authentic sub- 
unit. Since it has been demonstrated that the pro- 
cessing of so called pre-proteins is carried out in 
oocytes in a correct way [ Il,f6], it is likely that the 
observed difference in mobility is due to differences 
in the composition of the carbohydrate chains 
attached. Indeed, our experiments with the different 
glycosidases indicate that the hCG_cr related poiy- 
peptide synthesized in the oocytes contains, in con- 
trast to the native (Y subunit, high-mannose core oligo- 
saccharides attached to asparagine residues. These 
results suggest hat the glycosylation of the oocyte 
CY protein is limited to the initial addition of a pre- 
formed oligomannosyl core [ 171 and some but 
incomplete processing. We plan to study whether 
comparable results are obtained with the /3 subunit of 
hCG, which apart from 2 asparagine-linked oligo- 
saccharide units also contains 4 serine-linked carbo- 
hydrate chains [ 181. 
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